6223-83-2Relevant articles and documents
Net directed 180° aryl-aryl bond rotation in a prototypical achiral biaryl lactone synthetic molecular motor
Lin, Ying,Dahl, Bart J.,Branchaud, Bruce P.
, p. 8359 - 8362 (2005)
Net directed 180° bond rotation was achieved through diastereoselective ring-opening reactions in an achiral biaryl lactone using a chiral nucleophile followed by re-lactonization. The efficiency of the directed bond rotation has been determined by HPLC-MS to be 50% and 20% with two different chiral nucleophiles. These results demonstrate the potential for a prototype of a chemically driven synthetic molecular motor which has the advantages of both simplicity and flexibility in operation and is the first example of the use of a chiral auxiliary to induce transient axial chirality resulting in net directed bond rotation.
Nitroaromatics as n-type organic semiconductors for field effect transistors
Ghamari, Pegah,Hamzehpoor, Ehsan,Niazi, Muhammad Rizwan,Perepichka, Dmitrii F.,Perepichka, Igor F.
supporting information, p. 6432 - 6435 (2020/06/21)
The nitro group (NO2) is one of the most common electron-withdrawing groups but it has rarely been used in the design of organic semiconductors (OSCs). Herein, we report the n-type semiconducting behavior of simple fluorenone derivatives functionalized with NO2and CN groups. While the electron mobilities measured in the thin film field-effect transistors are modest (10?6-10?4cm2V?1s?1), the nitrofluorenone OSCs offer excellent air-stability and remarkable tunability of energy levelsviafacile modification of the substitution pattern. We study the effect of substituents on the electrochemical properties, molecular and crystal structure, and the charge transport properties of nitrofluorenones to revitalize the underestimated potential of NO2functionalization in organic electronics.
Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
-
Page/Page column 27, (2008/06/13)
The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions of compounds of Formula (A): wherein Ar, Y, R1 and q are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness, promotion of wakefulness, treatment of Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, treatment of attention deficit hyperactivity disorder ("ADHD"), enhancing function in disorders associated with hypofunctionality of the cerebral cortex, including, but not limited to, depression, schizophrenia, fatigue, in particular, fatigue associated with neurologic disease, such as multiple sclerosis, chronic fatigue syndrome, and improvement of cognitive dysfunction.
